292 related articles for article (PubMed ID: 34206474)
21. Plasmid profiles among some ESKAPE pathogens in a tertiary care centre in south India.
Ragupathi NKD; Bakthavatchalam YD; Mathur P; Pragasam AK; Walia K; Ohri VC; Veeraraghavan B
Indian J Med Res; 2019 Feb; 149(2):222-231. PubMed ID: 31219087
[TBL] [Abstract][Full Text] [Related]
22. CRISPR-Based Gene Editing in
Junaid M; Thirapanmethee K; Khuntayaporn P; Chomnawang MT
Pharmaceuticals (Basel); 2023 Jun; 16(7):. PubMed ID: 37513832
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial Resistance in ESKAPE Pathogens.
De Oliveira DMP; Forde BM; Kidd TJ; Harris PNA; Schembri MA; Beatson SA; Paterson DL; Walker MJ
Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32404435
[TBL] [Abstract][Full Text] [Related]
24. Antimicrobial Resistance in
Lupo A; Haenni M; Madec JY
Microbiol Spectr; 2018 Jun; 6(3):. PubMed ID: 30101740
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and Phenotypic Antimicrobial Resistance among ESKAPE Bacteria and Enterobacterales Strains in Wild Birds.
Russo TP; Minichino A; Gargiulo A; Varriale L; Borrelli L; Pace A; Santaniello A; Pompameo M; Fioretti A; Dipineto L
Antibiotics (Basel); 2022 Dec; 11(12):. PubMed ID: 36551482
[TBL] [Abstract][Full Text] [Related]
26. The burden of hospital acquired infections and antimicrobial resistance.
Abban MK; Ayerakwa EA; Mosi L; Isawumi A
Heliyon; 2023 Oct; 9(10):e20561. PubMed ID: 37818001
[TBL] [Abstract][Full Text] [Related]
27. Bactericidal efficacy of atmospheric pressure non-thermal plasma (APNTP) against the ESKAPE pathogens.
Flynn PB; Higginbotham S; Alshraiedeh NH; Gorman SP; Graham WG; Gilmore BF
Int J Antimicrob Agents; 2015 Jul; 46(1):101-7. PubMed ID: 25963338
[TBL] [Abstract][Full Text] [Related]
28. Measurement and prediction of antimicrobial resistance in bloodstream infections by ESKAPE pathogens and Escherichia coli.
De Socio GV; Rubbioni P; Botta D; Cenci E; Belati A; Paggi R; Pasticci MB; Mencacci A
J Glob Antimicrob Resist; 2019 Dec; 19():154-160. PubMed ID: 31112804
[TBL] [Abstract][Full Text] [Related]
29. Clustered Regularly Interspaced Short Palindromic Repeat-Dependent, Biofilm-Specific Death of Pseudomonas aeruginosa Mediated by Increased Expression of Phage-Related Genes.
Heussler GE; Cady KC; Koeppen K; Bhuju S; Stanton BA; O'Toole GA
mBio; 2015 May; 6(3):e00129-15. PubMed ID: 25968642
[TBL] [Abstract][Full Text] [Related]
30. Ventilator-associated pneumonia caused by ESKAPE organisms: cause, clinical features, and management.
Sandiumenge A; Rello J
Curr Opin Pulm Med; 2012 May; 18(3):187-93. PubMed ID: 22366995
[TBL] [Abstract][Full Text] [Related]
31. Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.
Ma YX; Wang CY; Li YY; Li J; Wan QQ; Chen JH; Tay FR; Niu LN
Adv Sci (Weinh); 2020 Jan; 7(1):1901872. PubMed ID: 31921562
[TBL] [Abstract][Full Text] [Related]
32. Surveillance and comparison of antimicrobial susceptibility patterns of ESKAPE organisms isolated from patients with bacteraemia in South Africa, 2016 - 2017.
Ismail H; Lowman W; Govind CN; Swe Swe-Han K; Maloba MRB; Bamford C; Perovic O
S Afr Med J; 2019 Nov; 109(12):934-940. PubMed ID: 31865955
[TBL] [Abstract][Full Text] [Related]
33. Bacterial Antibiotic Resistance: The Most Critical Pathogens.
Mancuso G; Midiri A; Gerace E; Biondo C
Pathogens; 2021 Oct; 10(10):. PubMed ID: 34684258
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
Karlowsky JA; Hoban DJ; Hackel MA; Lob SH; Sahm DF
J Med Microbiol; 2017 Jan; 66(1):61-69. PubMed ID: 28051952
[TBL] [Abstract][Full Text] [Related]
35. Clonal dispersion of Acinetobacter baumannii in an intensive care unit designed to patients COVID-19.
Durán-Manuel EM; Cruz-Cruz C; Ibáñez-Cervantes G; Bravata-Alcantará JC; Sosa-Hernández O; Delgado-Balbuena L; León-García G; Cortés-Ortíz IA; Cureño-Díaz MA; Castro-Escarpulli G; Vélez-Reséndiz JM; Bello-López JM
J Infect Dev Ctries; 2021 Jan; 15(1):58-68. PubMed ID: 33571146
[TBL] [Abstract][Full Text] [Related]
36. Bacteremia due to ESKAPE pathogens: An emerging problem in cancer patients.
El-Mahallawy HA; Hassan SS; El-Wakil M; Moneer MM
J Egypt Natl Canc Inst; 2016 Sep; 28(3):157-62. PubMed ID: 27268592
[TBL] [Abstract][Full Text] [Related]
37. Clinical relevance of the ESKAPE pathogens.
Pendleton JN; Gorman SP; Gilmore BF
Expert Rev Anti Infect Ther; 2013 Mar; 11(3):297-308. PubMed ID: 23458769
[TBL] [Abstract][Full Text] [Related]
38. Detection of ESKAPE Bacterial Pathogens at the Point of Care Using Isothermal DNA-Based Assays in a Portable Degas-Actuated Microfluidic Diagnostic Assay Platform.
Renner LD; Zan J; Hu LI; Martinez M; Resto PJ; Siegel AC; Torres C; Hall SB; Slezak TR; Nguyen TH; Weibel DB
Appl Environ Microbiol; 2017 Feb; 83(4):. PubMed ID: 27986722
[TBL] [Abstract][Full Text] [Related]
39. Escaping mechanisms of ESKAPE pathogens from antibiotics and their targeting by natural compounds.
Jadimurthy R; Mayegowda SB; Nayak SC; Mohan CD; Rangappa KS
Biotechnol Rep (Amst); 2022 Jun; 34():e00728. PubMed ID: 35686013
[TBL] [Abstract][Full Text] [Related]
40. Acquired Genetic Elements that Contribute to Antimicrobial Resistance in Frequent Gram-Negative Causative Agents of Healthcare-Associated Infections.
Cruz-López F; Villarreal-Treviño L; Camacho-Ortiz A; Morfín-Otero R; Flores-Treviño S; Garza-González E
Am J Med Sci; 2020 Dec; 360(6):631-640. PubMed ID: 32747008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
